ONCY receives Nasdaq minimum bid price deficiency notice, compliance window runs to January 19, 2027
A Nasdaq deficiency letter landed at Oncolytics Biotech Inc. on July 20, 2026, triggering a formal compliance clock for shares of the San Diego-based biotech. The Nasdaq Listing Qualifications Staff notified the…